Kyowa Kirin Co (Kyowa Kirin Co) Asset Impairment Charge : $0 Mil (TTM As of Sep. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Kyowa Kirin Co Asset Impairment Charge?

Kyowa Kirin Co's Asset Impairment Charge for the three months ended in Sep. 2023 was $0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2023 was $0 Mil.

Kyowa Kirin Co Asset Impairment Charge Historical Data

The historical data trend for Kyowa Kirin Co's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyowa Kirin Co Asset Impairment Charge Chart

Kyowa Kirin Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Asset Impairment Charge

Get a 7-Day Free Trial

Kyowa Kirin Co Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Kyowa Kirin Co Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

Kyowa Kirin Co Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Kyowa Kirin Co's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Kyowa Kirin Co (Kyowa Kirin Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyowa Kirin Co Ltd (OTCPK:KYKOF) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

KYKOY:USA 4151:Japan

Address

1-9-2,Otemachi, Chiyoda-ku, Otemachi Financial City Grand Cube, Tokyo, JPN, 100-0004

Website

http://www.kyowa-kirin.com

Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Its operations emphasize four categories: nephrology, oncology, immunology and allergy, and the central nervous system. The company has two reportable segments, Pharmaceuticals and Biochemicals. The pharmaceuticals business manufactures and sells ethical pharmaceuticals, diagnostic reagents, and other products. The biochemicals business manufactures and sells raw materials for pharmaceutical and industrial use, mainly amino acids, nucleic acids and related compounds, healthcare products, and others.